Dr. Raza Bokhari, Former Executive Chairman and CEO of FSD Pharma, Provides Litigation Update
Files a Motion For Leave Of Court and raises concern over investment strategy of FSD Pharma
- Philadelphia, Pennsylvania--(Newsfile Corp. - October 16, 2023) - Dr. Raza Bokhari, the former CEO and Executive Chairman of FSD Pharma intends to challenge the fairness of the Court proceedings recently held in Toronto, Canada.
- Counsels for Dr. Bokhari have filed a motion for leave to appeal the recent decision of the Commercial List Court.
- The purpose of the appeal is to set aside the Arbitral Award issued by Arbitrator J. Douglas Cunningham in November 2022, relating to FSD Pharma's termination of Dr. Bokhari's employment.
- The non-disclosure is contrary to the Arbitrator's disclosure obligations under Section 11 of the Ontario Arbitration Act, 1991, S.O.